Showa Denko (SDK) Announces 2015 Consolidated Financial Results.
TOKYO, Feb 10, 2016 - (JCN Newswire) - Showa Denko K.K. ("SDK"; TSE:4004) today announced its 2015 consolidated financial results.
- 2015 Financial Results (Summary):
- 2015 Consolidated Financial Statements:
The Company today also issued two supporting releases.
SDK to Consolidate Its Shares, Change Number of Shares per Share Unit, and Partially Amend the Articles of Incorporation
SDK to Introduce Performance-linked Stock Compensation Scheme
About Showa Denko K.K.
Showa Denko K.K. ("SDK"; TSE:4004,US:SHWDF) is a major manufacturer and marketer of chemical products serving a wide range of fields ranging from heavy industry to the electronic and computer industries. The Petrochemicals Sector provides cracker products such as ethylene and propylene, the Chemicals Sector provides industrial and high-performance gasses and chemicals and high-purity gases and chemicals for the semiconductor industry, and the Inorganics Sector provides ceramics products such as alumina, abrasive, refractory and graphite electrodes and fine carbon products. Today, the Aluminum Sector provides aluminum materials and high-value-added fabricated aluminum, the Electronics Sector provides HD media, compound semiconductors such as ultra high-bright LEDs and rare earth magnetic alloys, and the Advanced Battery Materials Department (ABM) provides lithium-ion battery components. For more information, please visit www.sdk.co.jp/english/.
Source: Showa Denko K.K.
Showa Denko K.K. (SDK) Public Relations Office T: +81-3-5470-3235 E: Sdk_Prir@showadenko.com
Copyright 2016 JCN Newswire . All rights reserved.
|Printer friendly Cite/link Email Feedback|
|Article Type:||Financial report|
|Date:||Feb 10, 2016|
|Previous Article:||SDK to Consolidate Its Shares, Change Number of Shares per Share Unit, and Partially Amend the Articles of Incorporation.|
|Next Article:||Phase III Trial Results of Eisai's Anticancer Agent Halaven(R) in Soft Tissue Sarcoma Published in The Lancet.|